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Some methodological issues in biosurveillance‡
Ronald D. Fricker Jr∗†
This paper briefly summarizes a short course I gave at the 12th Biennial Centers for Disease Control and Prevention (CDC)
and Agency for Toxic Substances and Disease Registry (ATSDR) Symposium held in Decatur, Georgia on April 6, 2009. The
goal of this short course was to discuss various methodological issues of biosurveillance detection algorithms, with a focus on the
issues related to developing, evaluating, and implementing such algorithms. The PowerPoint slides from the complete talk can
be accessed at http://faculty.nps.edu/rdfricke/Biosurveillance.htm. Published in 2011 by John Wiley
& Sons, Ltd.
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1. Introduction
Homeland Security Presidential Directive 21 (HSPD-21) [1] defines biosurveillance as ‘the process of active data-
gathering with appropriate analysis and interpretation of biosphere data that might relate to disease activity and threats
to human or animal health—whether infectious, toxic, metabolic, or otherwise, and regardless of intentional or natural
origin—to achieve early warning of health threats, early detection of health events, and overall situational awareness of
disease activity.’
HSPD-21 further defines epidemiologic surveillance as ‘the process of actively gathering and analyzing data related to
human health and disease in a population in order to obtain early warning of human health events, rapid characterization
of human disease events, and overall situational awareness of disease activity in the human population.’ For the purposes
of this paper, I discuss biosurveillance within the context of epidemiologic surveillance (and often in the more specific
context of syndromic surveillance), though biosurveillance clearly applies to a broader class of public health surveillance
problems.
As HSPD-21 states, biosurveillance systems have two main objectives: early event detection (EED) and situational
awareness (SA). I define EED and SA as:
• EED: Gathering and analyzing data in advance of diagnostic case confirmation to give early warning of a possible
outbreak and, should an outbreak exist, provide early detection.
• SA: The real-time analysis and display of health data to monitor the location, magnitude, and spread of an outbreak.
For a more detailed discussion of SA, see www.satechnologies.com/situation_awareness/.
Use of biosurveillance, in the form of epidemiological surveillance, is widespread. In 2007–2008, Buehler et al. [2]
sent surveys to public health officials in 59 state, territorial, and large local jurisdictions. Fifty-two officials responded
(an 88 percent response rate) representing jurisdictions containing 94 percent of U.S. population. They found:
• Eighty-three percent reported conducting biosurveillance for a median of three years.
• Emergency room (ER) data are most commonly used for biosurveillance (84 percent), followed by:
◦ Outpatient clinic visits (49 percent)
◦ Over-the-counter (OTC) medication sales (44 percent)
◦ Calls to poison control centers (37 percent)
◦ School absenteeism (37 percent)
• Two-thirds said they are ‘highly’ or ‘somewhat’ likely to expand the use of biosurveillance in the next two years.
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In spite of this widespread and potentially expanding use of biosurveillance, questions remain about its utility and
effectiveness. Examples of papers that discuss various issues, challenges, and important research needs associated with
effective implementation and operation of electronic biosurveillance systems include [2--11].
In case studies of health departments in eight U.S. states, Uscher-Pines et al. [4] found that fewer than half had written
response protocols for responding to biosurveillance system alerts and the health departments reported conducting in-depth
investigations on fewer than 15 percent of biosurveillance system alerts. Further, Uscher-Pines et al. [4] said, ‘Although
many health departments noted that the original purpose of syndromic surveillance was early warning/detection, no
health department reported using systems for this purpose. Examples of typical statements included the following: ‘I
was a big supporter of syndromic surveillance for early warning early on, but now I am more realistic about the system’s
limitations.’
In the literature, Reingold [10] suggested that a compelling case for the implementation of biosurveillance systems has
yet to be made. Cooper [12] said, ‘To date no bio-terrorist attack has been detected in the United Kingdom, or elsewhere
in the world using syndromic surveillance systems.’ Stoto et al. [8] questioned whether biosurveillance systems can
achieve an effective early detection capability. And Green [5] said, ‘Syndromic surveillance systems, based on statistical
algorithms, will be of little value in early detection of bioterrorist outbreaks. Early on in the outbreak, there will be
cases serious enough to alert physicians and be given definitive diagnoses.’
The research challenges span many disciplines and problems:
• Legal and regulatory challenges to gain access to data.
• Technological challenges related to designing computer hardware and software for collecting and assembling data.
• Ethical and procedural issues inherent in managing and safeguarding data.
• Analytical challenges of assessing the likelihood of outbreaks and of displaying data to enhance SA.
• Managerial challenges of effectively assembling and operating the entire system.
Much of the continuing controversy surrounding biosurveillance stems from its initial focus on EED, a use that
requires a number of still unproven assumptions, including:
• Leading indicators of outbreaks exist in pre-diagnosis health-related data of adequate strength such that they are
statistically detectable with satisfactory power.
• The leading indicators occur sufficiently far in advance of clinical diagnoses so that, when found, they provide the
public health community with enough advance notice to take action.
• Statistical detection algorithms exist that produce signals reliable enough to warrant continued dedication of public
health resources to investigate the signals.
Of course, a myopic focus only on EED in biosurveillance systems misses important benefits that such systems can
provide, particularly the potential to significantly advance and modernize the practice of public health surveillance. For
example, whether or not biosurveillance systems prove effective at the early detection of bioterrorism, they are likely
to have a significant and continuing role in the detection and tracking of seasonal and pandemic flu, as well as other
naturally occurring disease outbreaks. This latter function is echoed in an Institute of Medicine report on Microbial
Threats to Health by Smolinski, Hamburg, and Lederberg [13]: ‘[S]yndromic surveillance is likely to be increasingly
helpful in the detection and monitoring of epidemics, as well as the evaluation of health care utilization for infectious
diseases.’ In a similar vein, Uscher-Pines et al. [4] quote a public health official: ‘Health departments should not be at
the mercy of alerts; they need to develop their own uses for syndromic surveillance.’
In terms of bioterrorism, Stoto [14] states that electronic biosurveillance systems build links between public health
and health care providers—links that could prove to be critical for consequence management should a bioterrorism
attack occur. Furthermore, Sosin [11] points out that electronic biosurveillance systems can act as a safety net, should
the existing avenues of detection fail to detect an attack, hence countermeasures can be taken swiftly, and then can
provide additional lead-time to public health authorities so that they can take more effective public health actions.
As a safety net, a biosurveillance system does not necessarily have to signal earlier than the first clinical diagnosis to be
useful. To illustrate, a Dutch biologist conducting automated salmonella surveillance related that the surveillance system
has detected outbreaks whose occurrence was somehow missed by sentinel physicians [15]. And unusual indicators in
a biosurveillance system (not necessarily a signal from an early event algorithm) may give public health organizations
time to begin organizing and marshalling resources in advance of a confirmed case and/or provide critical information
about how and where to apply resources.
As someone who conducts research into statistical detection algorithms, I am not convinced by the argument that poor
EED performance in existing systems means biosurveillance should not be used for EED. Rather, it suggests that more
research is required to identify under what conditions biosurveillance EED can be effectively used, including those types
of outbreaks that are detectable using available data and the types of algorithms that are more effective. And that was
the purpose of the Centers for Disease Control and Prevention (CDC) and Agency for Toxic Substances and Disease
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Registry (ATSDR) Symposium short course: to point out methodological issues in biosurveillance that require additional
research. The following section summarizes some of these issues.
2. Some issues in biosurveillance
2.1. Are statistical methods useful for EED?
A critical question that requires further research is under what circumstances statistical detection algorithms can usefully
detect an outbreak. Specifically, an outbreak that is sufficiently large, geographically concentrated, or easy to diagnose,
will likely be detected by a clinician prior to detection by a statistical algorithm. Similarly, a small or diffuse outbreak
is also unlikely to be detected by a statistical algorithm faster than a clinician (assuming the algorithm has sufficient
power to detect such an outbreak at all). That means statistical methods are of value only when the outbreak is large or
concentrated enough to be detectable but not so large that the outbreak is obvious, combined with the situation where
the type of outbreak is sufficiently hard to diagnose that medical professionals are likely to miss it for some time.
Figure 1 from [6] illustrates the point. The relevant research question is: For which diseases and under what medical
conditions does the area within the dotted line exist? By ‘exist’ I mean that an outbreak is more likely to be detected by
the statistical algorithm than by a medical or public health practitioner, as in both cases ‘detection’ is a stochastic event.
The implication is that, for those types of outbreaks for which such an area does not exist, EED using biosurveillance
systems should not be attempted.
Very little research has been published in this area. In an effort to explore the question, I conducted some simple
simulations comparing the probability that a clinician diagnoses a bio-agent prior to a statistical algorithm signaling. The
setup is as follows. A random number N of people present at an ER each day with flu-like symptoms, with E(N )=100
and N =20. In addition, k people present daily at the ER with flu-like symptoms but who have been exposed to a
bio-agent, 0k50, where k is fixed for a given simulation run. With probability p those exposed to the bio-agent have
extreme symptoms that a clinician can easily diagnose, meaning that if such a person goes to the ER the physician
diagnoses the bio-agent with certainty. A biosurveillance system is monitoring the daily counts of people presenting
with flu-like symptoms. Using a CUSUM algorithm, the threshold is set so that the average time between false signals
is 30 days. The question is, for a particular combination of p and k, what is the probability that the clinician diagnoses
a bio-agent case before the biosurveillance system signals?
Figure 2 shows the results of the simulation, where the surface is the probability that the clinician diagnoses a
bio-agent case before the biosurveillance system signals for various combinations of p and k. The horizontal axis to the
left is p, varying from 0.1 at the far left to 0. The horizontal axis to the right is for k, varying from 0 on the left to
50 at the far right. As expected, Figure 2 shows that as p gets smaller the clinician has less of a chance of detecting
first and when p is larger the clinician has a higher probability. Similarly, for k<8 the statistical algorithm has a harder
Figure 1. Additional research is required to determine under what conditions statistical detection algorithms can ‘add value.’
That is, for which types of outbreaks does the region defined by the dotted line exist? Figure reprinted from [6].
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Figure 2. The probability that a clinician diagnoses a bio-agent case prior to a biosurveillance system signaling as a function of
the probability of an extreme bio-agent case (p) and the daily number presenting who were exposed to the bio-agent (k).
time signaling before the clinician and, interestingly, as k increases beyond eight the detection algorithm gains little
additional power.
What the plot shows is that the clinician has a 50 percent chance of diagnosing first when p=0.01 (one person in
100 exposed to the bio-agent develops obvious symptoms) and 8k50. In comparison, the clinician has a 75 percent
chance of diagnosing first when p=0.025 (one person in 40) and 8k50. And, the clinician has a 90–95 percent
chance of diagnosing first when p=0.05 (one person in 20) and 10k50. To me, the simulation suggests that there
is a role for statistical algorithms in biosurveillance when the pathogen is hard to diagnose and/or when small numbers
are presenting.
Yet, obviously, this is an overly simplified simulation. A more realistic simulation would allow k to be stochastic, it
would allow the p for each individual exposed to the bio-agent to change (presumably increase) over time, etc. Further,
as a reviewer pointed out, these simulations may be biased in favor of clinicians as it assumes perfect detection once a
patient presents. In the real world the clinician would have to recognize the bioterrorism agent and then be sure enough
of his or her finding that he or she would be willing to take action. This would take some time, particularly if it is
required with some confirmatory tests, while the simulation assumed immediate diagnosis. And, of course, the clinician
might misdiagnose.
Clearly this is an area ripe for further research, since the only other effort of which I am aware is [16] who conducted a
very detailed simulation study comparing the performance of a syndromic surveillance system with clinical case findings
for a release of inhalational anthrax in the Norfolk, Virginia area. With more research, these types of assessments would
begin to definitively answer the question of when and how biosurveillance might be used for effective EED. For example,
Buckeridge et al. [16] concluded:
Our results suggest that syndromic surveillance could detect an inhalational anthrax outbreak before clinical case
finding. However, we regularly observed a detection benefit only when syndromic surveillance operated at a
specificity in the range of 0.9, which corresponds to 1 false alarm every 10 days. When operating at this relatively
low specificity with a concomitant high sensitivity, syndromic surveillance detected outbreaks, on average, 1 day
before clinical case finding did.
2.2. Looking for everything means it is harder to find any one thing
A significant challenge in designing detection algorithms for biosurveillance is that the type of outbreak to be detected
is left undefined. Rather, the goal is to find any anomalous deviation from the usual incidence of a disease or syndrome,
where ‘any anomalous deviation’ is not specified.
Consider an analogous situation in which you are given the picture in Figure 3 and asked to identify anything unusual.
Clearly, there are a lot of potentially unusual things in the picture so that, without defining what ‘unusual’ means, one
could flag any number of possible items. Contrast that with the more specific goal of identifying whether Osama bin
Laden is present in the picture. A more focused goal like this improves detection in two ways: (1) it reduces false
positives, as we can now rule out signaling on other unusual events and (2) it allows us to more precisely focus our
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Figure 3. Is there anything unusual in this picture? [17].












Figure 4. Comparison of expected times to signal for a shift from f0 = N (0,1) to f1 = N (,1), 02, for four detection
algorithms (Shewhart, EWMA, CUSUM, and RTR). See [18] for additional details.
search, potentially making it more efficient and/or effective at detecting bin Laden. (Did you find him? Of course, being
more specific in the anomalies to be detected does not imply that the detection will then be easy.)
In hypothesis testing terms, it is as if one were given two sets of data, with the null and alternative hypotheses
left undefined, and asked to evaluate whether there is anything unusual in one data set compared with the other. One
approach to such a problem is to conduct a nonparametric test of the hypothesis that the two sets of data come from the
same distribution, but such a test has less power to detect a particular difference between the two sets of data, such as
that the mean of one is greater than the mean of the other (assuming a difference in the means is the desired alternative
to be detected). Furthermore, note that even with the nonparametric test, we are testing a particular hypothesis. What if
it is the wrong one?
Figure 4 gives a more relevant example drawn from [18]. It shows the expected time to signal (‘ARL’) for four
detection schemes based on the Shewhart, EWMA, CUSUM, and RTR algorithms, where the data initially comes from
an N (0,1) distribution that subsequently experiences a mean shift to various alternative distributions N (,1), ||0. At
=0 it shows that the expected time to false signal was set equal for all four schemes. For >0, more effective detection
methods have shorter expected times to signal.
As implemented in this simulation, the EWMA was designed to look only for mean shifts. In contrast, the Shewhart
and CUSUM algorithms are ensemble schemes designed to look for both mean and variance shifts. And the RTR is a
nonparametric methodology designed to look for any distributional change. The result, as the figure shows, is that the
EWMA has the shortest expected time to signal for any >0, followed by the CUSUM, then the Shewhart, and then the
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RTR. That is, the EWMA, which is only looking for a mean shift, is more effective when such a shift occurs. In contrast,
the RTR is looking for any type of distributional change and hence it is less effective than the other three methods.
For biosurveillance systems it follows that performance can be improved if the events to be detected can be better
defined. Dembek et al. [19] identified 11 ‘clues to a deliberate epidemic:’
• A highly unusual event with large numbers of casualties




• Lower attack rates in protected individuals
• Dead animals
• Reverse or unnatural spread
• Unusual disease manifestation
• Downwind plume pattern
• Direct evidence.
This then suggests, for example, that instead of looking for any increase in the rate of illness across many different
syndromes, one might look for a significant increase in a particular syndrome in conjunction with a significant increase
in mortality or evidence of an unusual clustering of those with the syndrome. As with the ‘Where’s Osama?’ picture,
appropriately defining the alternatives will reduce false positives while making the signals themselves more meaningful.
Of course, as a reviewer pointed out, being overly specific in what a biosurveillance system is looking for is not
without its potential problems. In particular, in a bioterrorism setting where there is an intelligent adversary, if the
terrorists have knowledge of the precise signal being looked for they will likely use this information to their advantage
and mount an attack with a different signal signature. This type of adversarial back and forth is currently most evident
in airport passenger screening for detecting bombs and other weapons, but it applies similarly to the application of
biosurveillance to detect bioterrorism. This does not negate the previous point that more precisely defining the signals
to be detected will increase the sensitivity and specificity of biosurveillance systems. But it does suggest that the signals
of interest should not be made public and that biosurveillance systems need to be flexible so that they can adjust to
changing terrorist capabilities and tactics.
2.3. Existing methods do not apply directly to biosurveillance
Epidemiology traces its roots back to Dr John Snow who used statistical mapping techniques to help identify the cause
of a cholera outbreak in London in the mid-19th century. Since that time, the field has developed many and varied tools
for understanding factors affecting the health and illness of populations. Epidemiologists and public health professionals
are often called upon to determine the cause or causes of a particular disease outbreak, much as Dr Snow first did
almost two centuries ago. A defining feature of such an investigation is that the outbreak has already been identified.
The investigation is thus a retrospective exercise in trying to determine the cause of a particular outbreak.
In contrast, biosurveillance is a prospective exercise in monitoring populations for possible disease outbreaks. The
goal is to routinely evaluate data for evidence of an outbreak prior to the existence of a confirmed case (in fact, even
prior to any suspicion of an outbreak) and, as a result, the epidemiological tools and techniques developed over the past
two centuries generally do not apply to the biosurveillance problem. Public health practitioners have thus turned to the
field of industrial quality control, sometimes applying and adapting those tools directly to biosurveillance.
Industrial quality control traces its roots to 1931 when Walter A. Shewhart wrote Economic Control of Quality of
Manufactured Product, where he developed the concept of the control chart, a graphical statistical tool most commonly
used to control manufacturing processes. The success of Shewhart’s method in the industrial world lies in its simplicity.
Essentially one establishes control limits and as long as a statistic derived from the data, sequentially observed over
time, falls within the control limits the manufacturing process is assumed to be ‘in control.’ If one or more fall outside
the control limits then the process is examined to determine whether it is ‘out of control’ and requires adjustment.
Shewhart’s work gave rise to the field of statistical process control (SPC) and a large and still growing literature of
research into myriad statistical methods for controlling processes.
In industrial quality control, and thus SPC, it is often reasonable to assume that:
• as one controls the manufacturing process, the in-control distribution is (or can reasonably be assumed to be)
stationary;
• observations can be drawn from the process so they are independent (or nearly so);
• monitoring the process mean and standard deviation is usually sufficient;
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• the asymptotic distributions of the statistics being monitored are known and thus can be used to design appropriate
control charts;
• shifts, when they occur, remain until they are detected and corrective action taken; and
• temporal (as opposed to spatial) detection is the critical problem.
However, the general biosurveillance problem violates many, if not all, of these assumptions. For example:
• there is little to no control over disease incidence and thus the distribution of disease incidence is usually non-
stationary;
• observations (often daily counts) are autocorrelated, and the need for quick detection works against the idea of
taking measurements far apart to achieve (near) independence;
• in biosurveillance there is little information about what types of statistics are useful for monitoring—one is often
looking for anything that seems unusual;
• because individual observations are being monitored, the idea of asymptotic sampling distributions does not apply,
and the data often contain significant systematic effects that must be accounted for;
• outbreaks are transient, with disease incidence returning to its original state once an outbreak has run its course;
and
• identifying both spatial and temporal deviations are often critical.
This gap between existing SPC methods and the biosurveillance problem provides an area ripe for new research and,
indeed, quite a bit has been going on for the past decade or so. However, frequently epidemiologists and biostatisticians
have attempted to re-invent existing SPC methodology or have failed to incorporate decades of lessons learned from the
SPC literature. Perhaps this is because the research cultures and norms of medical and SPC communities have hindered
research collaboration. For example, the medical journals and literature emphasize evaluating algorithm performance on
the actual data whereas the SPC community emphasizes extensive simulation. Similarly, epidemiologists and biostatis-
ticians are steeped in the medical hypothesis testing language of sensitivity and specificity whereas SPC researchers
generally use measures of expected time to signal for assessing algorithm performance. The result is that biosurveillance
research done by medical researchers is largely unpublishable in the SPC journals and vice versa.
Yet, biosurveillance research would greatly benefit from collaboration between the two communities. And SPC research
would certainly benefit from advances in biosurveillance monitoring as there are manufacturing processes that have
characteristics similar to the biosurveillance problem (e.g. continuous monitoring of chemical processes). The challenge
to the research community is to find ways to break down the barriers to collaboration. This has been happening more
recently, with a number of SPC researchers in attendance at the 12th Biennial CDC & ATSDR Symposium, but finding
ways to encourage greater collaboration will facilitate advances in biosurveillance.
2.4. Algorithm performance evaluations need to be standardized and expanded
This leads to the next issue, which is that the lack of commonly accepted standards for evaluating detection algo-
rithms creates major impediments to research progress, including: (1) biosurveillance algorithm performance evaluations
published in the literature cannot be replicated, (2) the results often cannot be generalized to other settings, and (3) the
various results cannot easily be compared with one another. Published results often cannot be replicated or generalized
because many of the evaluations are based on demonstrating performance on a single data set that is usually not publicly
available. Performance comparisons are hindered by the same factors and compounded by a lack of consensus on the
appropriate performance metrics. Improvement is necessary in (at least) three areas: (1) the use of simulation, (2) stan-
dardization of evaluation metrics, and (3) encouraging those proposing new methods to make performance comparisons
with existing competing methods.
2.4.1. Using simulation to compare performance. As the performance of most proposed methods is demonstrated on
data that are not publicly available, it is very difficult and often impossible to compare the performance of the various
detection methods across the biosurveillance literature. This is often driven by the public health community’s desire to
see methods demonstrated on real data. Yet, precisely because the data are real, there is a lack of general availability of
such data to the research community due to confidentiality and privacy concerns.
One solution is to make real data more widely available. Shmueli and Burkom [3] say, ‘Currently syndromic data are
only available to researchers affiliated with a particular biosurveillance system or research group, for reasons of data
confidentiality and non-disclosure agreements. This a major obstacle in the way of scientific progress in both temporal
and spatio-temporal biosurveillance, and hopefully some data will be made available to academic researchers.’
However, seemingly unrecognized in this discussion is the fact that any real data set is simply one realization of a
stochastic process. Focusing only on a particular stream of data one fails to recognize and account for the full randomness
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of the underlying phenomenon. As per Fraker et al. [20]:
Evaluations and comparisons of statistical performance in public health surveillance often involve the use of real
surveillance over a past time period of interest. The outbreak locations in time are either assumed to be known or
outbreaks are artificially superimposed on the data. As pointed out by Woodall [21], this is rarely, if ever, the case
in the industrial literature where case study-type data are used only to illustrate the application of methods, not to
evaluate statistical performance.
In addition, even if some real data are made available, it will provide little to no information about what outbreaks
look like, particularly those associated with bioterrorism related events. The challenge, as Rolka et al. [22] have said,
‘ . . . is to develop improved methods for evaluating detection algorithms in light of the fact that we have little data about
outbreaks of many potential diseases that are of concern.’
Simulation is an alternative. Of course, it is very difficult to (stochastically) characterize, and thus simulate, all the
detailed features characteristic of the normal or baseline state of disease incidence, as well as the various outbreak
conditions. However, one could also make similar statements about industrial quality control problems. Yet that field, over
time, has come to use various data abstraction conventions that facilitate simulation and, as a result, allow comparisons
between methods and across the literature. As Rolka et al. [23] said, ‘Reliance on the use of Monte Carlo simulation in
the field of Statistics is well known. It has been this author’s experience that the technique is undervalued in the field
of Public Health because it has previously not been required.’ Monte Carlo simulation can:
• facilitate evaluating algorithms across many scenarios;
• eliminate unneeded/distracting real world complexities;
• allow clean and clear comparisons of algorithms; and
• make it easier to get at generalizable conclusions/results.
Developing appropriate simulation conventions will not be easy. The biosurveillance problem is complicated and not
well defined. Breaking out of the ‘my data are unique’ and ‘only real data are valid’ paradigms also will not be easy.
Furthermore, it is important to abstract the most important features of the problem to facilitate comparisons and, in
particular, being able to distinguish when and why various methods perform differently. Agreeing on what the ‘important
features’ of biosurveillance data will be challenging. However, it can be done. For examples of efforts in this direction,
see [24, 25].
2.4.2. Common performance metrics. The biosurveillance research community must settle on a commonly accepted
set of metrics for evaluating detection algorithm performance. Only then will it be possible to synthesize across the
literature to better understand which algorithms work better or worse under particular conditions. At issue, as Fraker
et al. [20] say, is that ‘[s]ubstantially more metrics have been proposed in the public health surveillance literature than in
the industrial monitoring literature’ and no consensus has yet arisen about which metrics are to be preferred. Proposed
metrics include:
• Sensitivity, specificity, and timeliness
• Sensitivity and predictive value positive
• Recurrence interval
• Expected delay and conditional expected delay (CED)
• Probability of successful detection (PSD)
• Area under the response operating characteristic (ROC) curve, activity monitoring operating characteristic (AMOC)
curve, and free response operating characteristic (FROC) curve
• Average run length (ARL), average overlapping run length (AORL), average time to signal given an outbreak,
average time between signal events (ATBSE), and average signal event length (ASEL)
In comparison, the SPC community almost exclusively uses the expected time to signal metrics to evaluate and
compare the algorithmic performance. I do not suggest that the ARL is appropriate for biosurveillance, but rather use
it to illustrate that another community has settled on a common measure for the benefit of that research. Unfortunately,
there is little similar consensus in the biosurveillance. See [3] for additional discussion.
2.4.3. More evaluation comparisons needed. As Woodall et al. [26] said, ‘The body of literature on health-related
surveillance is smaller than that on industrial surveillance, and is somewhat less mathematical in nature.’ Perhaps more
importantly, the trend in the biosurveillance detection algorithm literature is to propose a new method and illustrate its
performance on a set of data that is not publicly available without also comparing its performance with other commonly
accepted methods. We have already discussed how using a private data set hinders the community from being able
to generalize results across the literature. Not requiring individual authors to compare and contrast a new method’s
performance with existing methods exacerbates the problem.
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In a search of the biosurveillance literature, very few papers were found that conducted such comparisons. While I
surely missed some, the only papers I found were [23--25, 27--33]. That is only 10 papers. Even if I missed an equivalent
amount in my (somewhat cursory) search, that is substantially fewer than the various papers proposing new methods,
which means there has been relatively little comparison between methods, at least as published in the literature.
To again compare with the SPC community, one essentially cannot publish a paper on a new methodology in that
literature without an extensive set of (simulation) comparisons with the standard methods. Indeed, the literature encourages
such comparisons and one can even publish papers that simply compare existing methods under new conditions. Our
understanding of biosurveillance algorithm performance would be immeasurably improved by encouraging a whole raft
of such publications, even if they were done on proprietary data sets that could not be publicly released.
2.5. Monitoring for bioterrorism versus natural diseases: it is not necessarily the same
One benefit of biosurveillance systems designed for bioterrorism detection is that they can also be used to detect and
monitor natural diseases. However, it does not follow that a system operated for detecting natural diseases will be most
effective at detecting bioterrorism.
Perhaps Shmueli and Burkom [3] said it best:
Determining whether an abnormality is present in the data requires defining normal behavior. One complication
arises from the intended dual-use of biosurveillance systems for detecting natural and bioterror-related or pandemic
disease outbreaks, because the data footprint of a seasonal influenza epidemic is a target signal in the former context
but part of the background clutter in the latter. In the bioterrorism monitoring context, all usual seasonal influences
should be removed for sensitivity even at the peak and aftermath of a usual influenza outbreak.
At issue is that if a system that is signaling during a natural disease outbreak is not ‘re-set,’ then it cannot detect a
bioterrorism attack during that time. An analogy: the smoke alarm that goes off every time the oven is used is of little
use detecting a stove top fire when you are baking a cake.
This suggests that additional emphasis needs to be placed on operational paradigms and algorithm design. In particular,
during natural disease outbreaks systems must be designed to adjust for revised background incidence rates so that
system can look for further anomalies. In addition, the current practice of not resetting algorithms after a signal and, in
fact, using multiple sequential signals as evidence of an actual outbreak, should be recognized as practices detrimental
to detecting a bioterrorism attack.
Of course, this begs the question of whether it is even possible to adjust for a transient disease outbreak in any
reliable fashion that would then allow for further anomaly detection. If the main purpose of biosurveillance systems
is bioterrorism protection, then this is an important area of future research. After all, when would a smart bioterrorist
attack? During the flu season, of course.
2.6. Research into biosurveillance system design needed
Biosurveillance systems need to be designed as just that, systems. For example, a typical characteristic of biosurveillance
systems is that the data collection locations (generally hospitals and clinics) are in fixed locations that may or may not
correspond to a particular threat of either natural disease or bioterrorism. In order to provide comprehensive population
coverage, biosurveillance system operators are inclined to enlist as many hospitals and clinics as possible. However,
as the sources and types of data being monitored proliferate in a biosurveillance system, then so do the false positive
signals from the systems. Indeed, false positives have become an epidemic problem for some systems. As one researcher
[34] said, ‘. . .most health monitors. . .learned to ignore alarms triggered by their system. This is due to the excessive
false alarm rate that is typical of most systems—there is nearly an alarm every day!’
Furthermore, if the main purpose of biosurveillance is to guard against bioterrorism, then one should design algorithms
that can incorporate information about the adversary, particularly information about likely modes and locations of attack.
For example, Fricker and Banschbach [35] have developed a methodology for optimizing a (very simple) threshold
detection-based biosurveillance system that uses information about the probability of attack by location. In so doing,
they maximize the system-wide probability of detecting an ‘event of interest’ subject to a constraint on the expected
number of false signals by differentially setting detection thresholds at each location in accordance with the probability
that each location is attacked.
Using this or some similar methodology would allow public health officials to ‘tune’ their biosurveillance systems
to optimally detect various threats while explicitly accounting for organizational resource constraints available for
investigating and adjudicating signals. This would then allow practitioners to focus their public health surveillance
activities on locations or diseases that pose the greatest threat at a particular point in time. And, as the threat changes,
using the same hospitals and clinics, the system could then subsequently be tuned to optimally detect other threats. With
this approach large biosurveillance systems are an asset (as opposed to a burden because of excessive alarms).
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Figure 5. Map of the counties in the contiguous continental United States with their associated optimal thresholds and
associated probabilities of attack for the hypothetical example.
Figure 6. Plot of the optimal thresholds against probability of attack for the hypothetical example.
In an example, Fricker and Banschbach [35] show how one might optimally set thresholds on a hypothetical biosurveil-
lance system designed to simultaneously monitor all 3141 counties in the United States. For the purposes of illustration,
they used the proportion of the total population in a county as a surrogate for the probability that the county is attacked.
Assuming a maximum expected number of false signals of four per day (since this national system was assumed to
have resources sufficient to investigate four false positives per day), the system has an expected time to detect an attack
of three days. This is achieved with thresholds ranging from 0.91 for Los Angeles county, the county with the highest
probability of attack, to 6.92 for Loving county, the county with the lowest probability of attack. Figure 5 is a map
showing the probability of attack and thresholds by county.
Now, consider the system performance if one were to have used a common threshold for all the counties of 3.018,
which achieves the same expected number of false signals (four per day), the expected time to detection would more
than double to 6 12 days. This decrease in sensitivity occurs because the system is less able to detect an attack in those
locations most likely to be attacked. Conversely, setting a common threshold of 2.433 to achieve an expected time to
detect of three days results in an almost sixfold increase in the expected number of false signals to 23.5 per day.
Figure 6 shows a plot of the optimal thresholds versus the probability of attack for all of the counties. What the plot
shows is that the counties with a high probability of attack have low thresholds. These low thresholds make false positives
in those locations more likely, but they also make it much more likely that an actual attack will be readily detected.
Conversely, the counties with very low probabilities of attack have high thresholds making it very difficult to detect an
attack but, on the other hand, these counties are being monitored at a level consistent with their risk of attack. That is,
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the optimization has made the necessary trade-off of probability of detection against the likelihood of false signals to
maximize the probability of detecting an attack somewhere in the country within a manageable false signal rate.
Much more work needs to be done in this area.
3. Discussion and recommendations
In the short course at the 12th Biennial CDC & ATSDR Symposium and in this paper I have attempted to lay out various
biosurveillance methodological challenges. The goal was to discuss some current issues in biosurveillance, particularly
with respect to detection algorithms. My viewpoint and suggestions are based on an industrial SPC background and, in
my opinion, biosurveillance research has yet to fully tap the SPC literature and expertise. In addition, other disciplines
have much to offer to the biosurveillance problem as well:
• Operations research: Optimizing biosurveillance system performance is a non-trivial problem.
• Systems engineering: Biosurveillance systems are complex systems that require careful design.
• Game theory: In a bioterrorism context, there is an autonomous, willful adversary who makes specific choices about
when and where to attack.
This paper is not meant to be critical of the current state of the art, which has come a long way in the past decade, but
rather to provide something of an organized set of issues as a potential research ‘road map’ for the community. In so doing,
I have posed more problems than solutions, highlighting some of the open issues, including the:
• benefits of better specifying the events to be detected;
• lack of standard evaluation methods and metrics in the literature;
• utility of using more Monte Carlo methods for algorithm evaluation; and
• need to take a systems-design approach to improve EED performance.
In this paper, I focused quite a bit on the need for more and better comparisons between detection methods, and I
have suggested that simulation has a role to play in such comparisons. At issue is that the sheer plethora of methods
that have been proposed in the literature raise questions that are, thus far, largely unanswered:
• Under what conditions do the various detection algorithms work best?
• Which methods are most sensitive at detecting a particular type of outbreak?
• Are some methods less effective with certain types of background data?
• Etc.
To answer these and other questions, I recommend encouraging on-going research that conducts comparisons between
methods under various conditions, both on real and simulated data. In a related vein, the community should promote
research into stochastically characterizing data (both normal background and outbreak) so that simulated data can be
made as realistic as possible. As a referee pointed out, an ancillary benefit is that ‘if the stochastic structure of the data
is understood (e.g. Autoregressive Integrated Moving Average (ARIMA) model) then the data can often be transformed
to yield independent data.’ This alone would go a long way in bridging the gap between traditional SPC methods and
their application to the biosurveillance problem.
In addition, in my opinion, competitions (e.g. Defense Advanced Research Projects Agency (DARPA)-sponsored
Bio-Advanced Leading Indicator Recognition Technology (ALIRT) competition, 2001–2004) are of limited utility. The
biosurveillance problem does not lend itself to a single ‘solution’ arising from a competition using one set of real data
since the best performer on one particular data set does not mean that it will be the best under other conditions or that
the results are generalizable.
Further, to be able to effectively synthesize results from these comparisons, the community needs to begin using a
common set of metrics. To that end, I suggest convening a panel of experts akin to (or perhaps exactly) a National
Academies panel to conduct the requisite research and produce a report with authoritative recommendations on the
metrics that the community should use.
Returning to the original question of whether statistical methods are useful for EED, I suggest that we really do not
know yet. That is, while some current systems have given EED a ‘bad rap’ because of an excessive number of alarms,
whether the systems and their associated detection algorithms can be modified so that they appropriately minimize false
positive signals while maintaining sufficient sensitivity to actual outbreaks/attacks is still an open question. Certainly
the simple simulation presented in Section 2.1 and the work by Buckeridge et al. [16] suggest that biosurveillance for
EED has a role in some situations:
• As a primary detection tool for rare, hard to diagnose diseases/agents.
• As a back-up to clinicians for moderately sized outbreaks that are moderately hard to diagnose.
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Further rigorous, scientific studies are still required to clearly define and refine that role, as well as the limitations of
biosurveillance.
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